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Background/Introduction
The status of lung cancer surgery in UK has seen many
changes over the last 20 years, with innovations in surgi-
cal technique and investigatory modalities together with
significant organisational changes.
Aims/Objectives
To assess how these changes have impacted on an indi-
vidual surgical practice spanning this era.
Method
We have retrospectively reviewed a single-surgeon practice
from consultant appointment to present (1997-2015). We
studied 1717 consecutive lung cancer operations: 962
lobectomy, 250 extended lobectomy, 57 pneumonectomy
296 sublobar, 43 open/close. Additionally, 710 surgical sta-
ging procedures were performed. We analysed trends with
time in type of procedure; approach used (VATS/Open);
open/close rates and in-hospital mortality.
Results
1566 anatomic resections were performed (87 cases/
year, 67-130). The following trends were observed:
1) Related to the disease itself
- A significant decrease in pneumonectomy rates (p <
0.001)
- An inversely proportional, increasing use of sleeve-
resections (p = 0.088).
2) Related to surgical technique
- An increasing number of anatomical segmentec-
tomies (p < 0.001)
- Stable rates of non-anatomical wedge resections
(mean 6.3%, p = 0.908)
- An increasing proportion of VATS resection, both
for lobectomies (p < 0.001) and segmentectomies (34.1
vs.14.6%, p < 0.001).
3) Related to healthcare system
- A significant decrease in use of surgical mediastinal
staging, particularly after 2010 (p < 0.001)
- A significant decrease in-hospital mortality (mean
5.8%, p = 0.004)
- A significant reduction of open/close rates, particu-
larly after 2004 (4.8 vs.0.65%, p < 0.001).
Discussion/Conclusion
There has been significant evolution in lung cancer sur-
gery over the last two decades, which is reflected in this
individual surgeon’s practice. Whilst increased surgical
experience may partly explain the changes, most impor-
tant factors include: a change in the proportion of cen-
tral squamous and peripheral adenocarcinomas; earlier
tumour detection, facilitating more VATS and lung-
sparing surgery; improved perioperative care and use of
lesser resections, reducing mortality; new techniques in
staging (CT-PET,EBUS) reducing the need for surgical
staging and the number of futile thoracotomies.
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